Laboratorios Farmaceuticos Rovi SA
(LTS:0ILL)
€
77.5
0.90798 (1.19%)
Market Cap: 3.96 Bil
Enterprise Value: 4.03 Bil
PE Ratio: 27.43
PB Ratio: 8.67
GF Score: 84/100 - Q4 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 27, 2024€67.5 (-5.62%)Earnings
- Q2 2023 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 26, 2023€45.54 (+10.07%)Earnings
- Q4 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 28, 2023€41.7 (-0.08%)Earnings
- Laboratorios Farmaceuticos ROVI SA Capital Market Day 2022 TranscriptNov 23, 2022
- Q2 2022 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2022€60.97 (+1.79%)Earnings
- Q4 2021 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 23, 2022€70.73 (+1.67%)Earnings
- Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation TranscriptJul 28, 2021
- Full Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 24, 2021€45.5 (-1.15%)Earnings
- Half Year 2020 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 27, 2020€32.1 (+5.15%)Earnings
- Full Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptFeb 26, 2020€25.43 (+2.14%)Earnings
- Half Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call TranscriptJul 30, 2019€20Earnings
- Laboratorios Farmaceuticos Rovi, S.A. - Special Call TranscriptMar 19, 2019
Half Year 2021 Laboratorios Farmaceuticos ROVI SA Earnings Presentation Transcript
Jul 28, 2021 / 01:00PM GMT
Release Date Price:
€62.45
(+3.11%)
Javier Lopez;Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO
Presentation
Jul 28, 2021 / 01:00PM GMT
=====================
Corporate Participants
=====================
* Javier Lopez-Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO
* Juan Lopez-Belmonte Encina
Laboratorios Farmaceuticos Rovi, S.A. - CEO & Director
* Marta Campos MartÃÂnez
=====================
- -
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)